320 results on '"Holloway, Claire"'
Search Results
52. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters
53. Supine Breast MRI
54. Development and evaluation of a robust algorithm for computer-assisted detection of sentinel lymph node micrometastases
55. Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study
56. Assessing burnout among oncologists in Ontario, Canada.
57. Intraoperative Consultation for Axillary Sentinel Lymph Node Biopsy: An 8-Year Audit
58. Histiocytoid Variant of Lobular Carcinoma: A Triple Negative Case
59. An MRI/US/X-Ray Compatible Breast Localization Marker: In Vivo Evaluation 1
60. Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments
61. The Role of Cytokeratin 5/6 as an Adjunct Diagnostic Tool in Breast Core Needle Biopsies
62. The Role of Reexcision for Positive Margins in Optimizing Local Disease Control After Breast-Conserving Surgery for Cancer
63. Surgical management of early stage invasive breast cancer: a practice guideline
64. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments
65. Sensitivity of BRCA-1-Related Breast Cancer to Neoadjuvant Chemotherapy: Practical Implications
66. The Impact of Diagnostic Assessment Programs on the Diagnosis and Treatment of Colon and Rectal cancers in a Single Payer System
67. Determining the Cancer Diagnostic Interval Using Administrative Health Care Data in a Breast Cancer Cohort
68. A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks
69. Restructuring Skin Cancer Care in Ontario: A Provincial Plan.
70. Validity of Administrative Databases in Comparison to Medical Charts for Breast Cancer Treatment Data
71. Reduction in Wait-Times to Colonoscopy after Positive Fecal Occult Blood Test Among Patients having Colonoscopy in a Diagnostic Assessment Program Compared to Usual Care in Ontario's Organized Colorectal Cancer Screening Program
72. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care
73. Faster and better: Improving the diagnostic phase of lung cancer at a system level.
74. Whole-mount pathology of breast lumpectomy specimens improves detection of tumour margins and focality
75. Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators
76. Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: A feasibility study
77. 296 - Reduction in Wait-Times to Colonoscopy after Positive Fecal Occult Blood Test Among Patients having Colonoscopy in a Diagnostic Assessment Program Compared to Usual Care in Ontario's Organized Colorectal Cancer Screening Program
78. Wait Times for Breast Cancer Surgery: Effect of Magnetic Resonance Imaging and Preoperative Investigations on the Diagnostic Pathway
79. Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
80. A prospective study of mastectomy patients with and without delayed breast reconstruction: Long-term psychosocial functioning in the breast cancer survivorship period
81. Using surface markers for MRI guided breast conserving surgery: a feasibility survey
82. Sentinel node biopsy after neoadjuvant therapy: Relevance of sentinel node micrometastases, isolated tumor cells, and value of immunohistochemistry.
83. Sentinel node biopsy following neoadjuvant chemotherapy in biopsy proven node positive breast cancer: The SN FNAC study.
84. Supine breast MRI and assessment of future clinical applications
85. Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study
86. Improving Work-Up of the Abnormal Mammogram Through Organized Assessment: Results From the Ontario Breast Screening Program
87. Feasibility Evaluation of Radioimmunoguided Surgery of Breast Cancer
88. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways
89. Changes in Psychosocial Functioning 1 Year After Mastectomy Alone, Delayed Breast Reconstruction, or Immediate Breast Reconstruction
90. Measuring the Quality of Sentinel Lymph Node Biopsy in Breast Cancer Using Newly Developed Quality Indicators: A Feasibility Study
91. A human bone NOD/SCID mouse model to distinguish metastatic potential in primary breast cancers
92. Intraoperative Consultation for Axillary Sentinel Lymph Node Biopsy: An 8-Year Audit
93. Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series
94. A positive contrast, tri-modality tissue marker for breast tumour localization
95. Selective Application of Axillary Node Dissection in Elderly Women with Early Breast Cancer
96. Development of an MRI/x-ray/ultrasound compatible marker for pre-operative breast tumour localization
97. Part IV. Surgery for ductal carcinoma in situ
98. Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
99. Prospective Study of 2-[18F] Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study.
100. An MRI/US/X-Ray Compatible Breast Localization Marker: In Vivo Evaluation1.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.